CDH3 is highly expressed and promotes tumorigenesis in pancreatic cancer, gastric cancer, and breast cancer, while it is expressed at low levels and suppresses tumorigenesis in non-small-cell lung cancer, hepatocellular carcinoma and thyroid cancer [38–41]. Here, CDH3 is linked to thyroid gland carcinoma.